Trials / Unknown
UnknownNCT02348021
Leaders Free Japan
BF-14J01 Drug Coated Stent (DCS) Clinical Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 139 (estimated)
- Sponsor
- Biosensors Europe SA · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Prospective, multi-center, non-randomized, open-label trial designed to enroll 139 patients in Japan. All patients will receive a DCS and will be followed for 2 years.
Detailed description
In this study all patients will receive the a Drug Coated Stent and will receive one month Dual Anti Platelet Therapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Percutaneous coronary intervention (PCI) | |
| DRUG | Dual Anti Platelet Therapy | All patients will receive Dual Anti Platelet Therapy for one month |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-04-01
- Completion
- 2017-07-01
- First posted
- 2015-01-28
- Last updated
- 2015-09-29
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02348021. Inclusion in this directory is not an endorsement.